Title
Hysterectomy and Levonorgestrel Releasing Intrauterine System (LNG-IUS) in the Treatment of Menorrhagia
Hysterectomy and Levonorgestrel-releasing IUS in the Treatment of Menorrhagia
Phase
Phase 3Lead Sponsor
University of HelsinkiStudy Type
InterventionalStatus
Completed Results PostedIndication/Condition
MenorrhagiaIntervention/Treatment
norgestrel ...Study Participants
236A randomised study including 236 women referred for essential menorrhagia to five university hospitals in Finland was conducted to compare the cost-effectiveness and the quality of life issues in the treatment of menorrhagia.Participants were randomly assigned to treatment with LNG-IUS (n=119), or hysterectomy (n=117), and were monitored for ten years. The primary outcome measures were health related quality of life (HRQoL), other measures of psychosocial well-being (anxiety, depression, sexual functioning), and costs.
A randomized VUOKKO trial was conducted between 1994-2008 to study hysterectomy and LNG-IUS in the treatment of menorrhagia.Overall, 236 women aged 35 to 49 years who were menstruating, had completed their family size, and were eligible for both treatments were randomized to either receive a LNG-IUS (n=119) or undergo hysterectomy (n=117). The follow-up visits took place six months and 12 months after the treatment, and again five and ten years after the randomization. The primary outcome measures were health related quality of life (HRQoL), other measures of psychosocial well-being (anxiety, depression, sexual functioning), and costs. The amount of menstrual blood loss was objectively measured before treatment and after one and five years. The one year the results were published in 2001 (Lancet 2001;357:273) and the five year results in 2004 (JAMA 2004; 291:1456).
LNG-IUS releasing 25 microg of levonorgestrel
operation
Levonorgestrel releasing intrauterine system
Inclusion Criteria: heavy menstrual bleeding 35-49 years were menstruating had completed their family size were eligible for both treatments Exclusion Criteria: submucous fibroids endometrial polyps ovarian tumours or cysts, cervical pathology urinary and bowel symptoms or pain due to large fibroids lack of indication for hysterectomy history of malignancies menopause severe depression metrorrhagia as a main complaint previous treatment failure with LNG-IUS severe acne uterine malformation
| Event Type | Organ System | Event Term | LNG-IUS | Hysterectomy |
|---|
HRQoL was measured by the 5-Dimensional EuroQol (EQ-5D) questionnaire which measures HRQoL in 5 dimensions of life (scale 0-1)(from very poor=0 to very good=5). The results are the change of HRQoL from baseline at 5 years (EQ-5D score at 5 years - EQ-5D score at baseline)
Outcome Measure Data Not Reported
Outcome Measure Data Not Reported
